USD 126.38 Billion
Immunotherapy Drugs Market Size, Share, Growth Analysis, By Type (Antibody Drugs Inhibitor Drugs, Interferons & Interleukins), By Application (Hematology, Neurology), By Route of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2354 |
Region:
Global |
Published Date: November, 2024
Pages:
174
|Tables:
64
|Figures:
70
Immunotherapy Drugs Market Insights
Global Immunotherapy Drugs Market size was valued at around USD 247.44 billion in 2022 and is expected to rise from USD 285.30 billion in 2023 to reach a value of USD 772.87 billion by 2031, at a CAGR of 15.3% over the forecast period (2024–2031).
The growth of the market is driven by rising prevalence of chronic illnesses globally. According to the International Diabetes Federation, it is estimated that 537 million adults in the age group of 20-79 years would be suffering from diabetes in 2021. Further, the number was predicted to surge to 783 million by 2045. Major companies operating in the market are focusing on new product findings and strategic collaborations to advance research studies regarding immunotherapy drugs. COVID-19 had a positive effect on the immunotherapy market due to the increase in demand for drugs associated with immunotherapy. For instance, an article featured in Open Forum Infection Diseases in January 2021 stated that treatment with monoclonal antibodies was most predicted effects in preventing the need for additional hospital or emergency department medical care among high-risk ambulatory individuals with early COVID-19 and that it was well-tolerated. Furthermore, the regulatory authorities' increased number of immunotherapy product approvals was also expected to accelerate market growth. Some of the factors contributing to the growth of immunotherapy drugs market include growing acceptance of targeted treatment over traditional treatment, introduction of biosimilars, lifestyle disorders, and increasing demand for monoclonal antibodies. In addition, other contributing factors to this growth include an increase in the number of collaborations, research laboratories, and direct and indirect investments in R&D by biotechnology and pharmaceutical companies, boosting the market.
Market Snapshot - 2024–2031
Global Market Size
Largest Segment
Cancer
Fastest Growth
Vaccines
Growth Rate
6.92% CAGR
Global Immunotherapy Drugs Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Immunotherapy Drugs Market Segmental Analysis
Global Immunotherapy Drugs Market is segmented by Type, Route of Administration, Application, Distribution Channel, End User and Region. Based on Type, the market is segmented into Antibody Drugs Inhibitor Drugs, Interferons and Interleukins, Cancer Vaccines, and Other Types. Based on Route of Administration, the market is segmented into Intravenous, Subcutaneous, and Other Routes of Administration. Based on Application, the market is segmented into Cancer, Autoimmune and Inflammatory Diseases, Hematology, Osteology, Neurology, and Other Applications. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies. Based on End User, the market is segmented into Hospitals, Long-Term Care Facilities, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis By Indication
Cancer generated the largest revenue share of about 91.10% in 2023 because of the introduction of cancer immunotherapies and rise in the incidence of cancer. According to Globocan 2020, breast cancer and lung cancer are the two most prevalent forms with a prevalence of about 11.7% and 11.4%, respectively. In April 2021, the market was further stirred up following the FDA's approval of Opdivo (nivolumab) for treatment in stomach cancer patients in combination with chemotherapy. These factors are expected to continue to drive the market, as the incidence of cancer is growing and developments in immunotherapies are advancing.
As more patients have several types of autoimmune diseases globally, and due to the local approvals of immunotherapy drugs in various geographies, Autoimmune Disorders Segment is expected to grow at the fastest growth rate during the forecast period. According to a research study from NCBI, 0.46% of people are believed to suffer from rheumatoid arthritis across the globe. For instance, regional approvals boost expansion: In February 2022, China's National Medical Products Administration cleared GSK's Benlysta (belimumab) for active lupus nephritis. As autoimmune disease knowledge and diagnosis continue to improve, this market is set to grow rapidly, offering opportunity for the producers of immunotherapies.
Analysis By Drug Type
Owing to growing R&D of therapeutic monoclonal antibodies, along with favorable government initiatives, the segment of monoclonal antibodies captured the largest share in 2023 with over 76.30%. This is due to the rise in diseases that are targeted for treatment using monoclonal antibodies, including various autoimmune disorders and several cancers. A recent instance of growing interest in monoclonal antibodies includes the acceptance by the U.S. FDA in May 2022 of the supplementary Biologics License Application for the priority review of Dupixent, dupilumab, for the treatment of prurigo nodularis. Government initiatives and support for funding in biotechnology-related research have rapidly enhanced the growth of this market.
During the forecast period, the vaccines segment is expected to grow at the fastest growth on account of growing clinical trial activity and strategic deals amongst the key players involved in vaccine development. This can be attributed to the increasing focus on prevention of infectious diseases, along with the development of new technologies. This includes mRNA-based vaccinations. For instance, Pfizer Inc. entered into a strategic collaboration agreement with BioNTech SE focused on the development of an mRNA-based vaccine preventing shingles. In addition, growing investments in vaccines-related research are highlighted by the fact that in March 2022, the National Institutes of Health announced the start of the Phase 1 study of three experimental HIV mRNA-based vaccines. Such aspects are likely to drive segmental growth for vaccines.
Global Immunotherapy Drugs Market By Drug Type
To get detailed analysis on other segments, Request For Free Sample Report
Immunotherapy Drugs Market Regional Insights
North America, with the largest share, headed the immunotherapy drugs market in 2023. The high acceptance rate of immunotherapy treatments, presence of key pharmaceutical companies, and favorable reimbursement policies are the primary factors for its leading position in the region. Due to the high prevalence of autoimmune diseases and cancer in the US and Canada, immunotherapies are in high demand. The presence of established research institutes and a proper healthcare system in this region accelerates the development and commercialization process of the immunotherapy drugs. Therefore, North America remains an attractive market for the companies that manufacture drugs on immunotherapy as most of them are considering this region for launching their product or commercializing it.
During the forecast period, the immunotherapy medicine market is projected to show its fastest growth in Asia-Pacific. This growth is attributed to increasing healthcare costs, a rising burden of autoimmune diseases and cancers, and improved infrastructure. Major markets, such as China, Japan, and India, are relatively large in terms of the patient population and have an emerging need for efficient therapies. Government endeavors and investments in research on biotechnology are further boosting the growth of the immunotherapy medications market in the region. Due to this, the development of immunotherapy drugs has a huge number of opportunities in Asia-Pacific. Many companies are expanding their presence in the region through strategies such as alliances, joint ventures, and market expansion.
Global Immunotherapy Drugs Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Immunotherapy Drugs Market Dynamics
Drivers
Increasing Prevalence of Chronic Diseases
- The increasing prevalence of chronic diseases, such as cancer, autoimmune diseases, and infectious diseases, has a severe effect on the immunotherapy pharmaceuticals market. As the population ages and lifestyles become different, there are increased demands for effective treatments. Immunotherapies can present potential cures, and their wider utilization is predicted to drive the growth of the market. The main factor that propels the demand for immunotherapy medications today is the increasing prevalence of chronic diseases, coupled with better awareness and diagnosis.
Advancing Research and Development
- The growth of the market is propelled by improvements in research and development, such as finding new targets and biomarkers. This, coupled with the introduction of better knowledge on the immune system and pathophysiology of disease, has led to the development of more targeted and powerful medicines. Innovations in technologies related to mRNA-based medicines and gene editing further extend the range of potential applications for immunotherapies. The market will thus keep growing as novel, innovative immunotherapies are identified, developed, and launched; there are many avenues for the treatment of various diseases yet to be discovered through continuous research.
Restraints
High Development Cost and Complexity
- Development of immunotherapy medications follows a tough process, further burdened with high expenses, limiting the market. The huge investments required in clinical trials, research, and development make reaching the market hard for immunotherapies. Another problem is that it makes the interaction of immune system components complex and requires treatments oriented to individuals or groups. All these factors together may prevent the entry of new entrants into the market and the development process of any new therapies, thereby delaying the market growth in the process.
Regulatory Challenges and Uncertainty
- The lack of clarity on market access and regulatory issues acts as a restraint to the immunotherapy medications market. This is attributed to the fact that the rapidly changing environment surrounding the drugs employed in immunotherapy creates much trouble for regulatory authorities, which may hamper the pace of approval. Tightened regulations further result in regional restrictions to market access, thus hindering access to novel medications across other regions. This regulatory burden is enhanced by post-marketing surveillance and requirements for pharmacovigilance, which interfere with growth in the market and create business challenges around the increasingly complex regulatory environment.
Request Free Customization of this report to help us to meet your business objectives.
Immunotherapy Drugs Market Competitive Landscape
The leading companies are focusing on growth strategies such as product enhancements, approvals of new products, and acquisitions to drive up their market shares. Sanofi and Kymab entered into an agreement in January 2021. Under this agreement, Sanofi would acquire Kymab for approximately USD 1.1 billion upfront. This added a monoclonal antibody, KY1005, to the pipeline.
Top Player’s Company Profiles
- Merck & Co., Inc. (United States)
- Johnson & Johnson Services, Inc. (United States)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- AstraZeneca (United Kingdom)
- Pfizer Inc. (United States)
- Amgen Inc. (United States)
- Novartis AG (Switzerland)
- Eli Lilly and Company (United States)
- Sanofi (France)
- Bristol-Myers Squibb Company (United States)
- Gilead Sciences, Inc. (United States)
- Takeda Pharmaceutical Company Limited (Japan)
- Teva Pharmaceutical Industries Ltd. (Israel)
- AbbVie Inc. (United States)
- GSK PLC (United Kingdom)
- Immunocore Holdings Plc (United Kingdom)
- Astellas Pharma Inc. (Japan)
- Genmab A/S (Denmark)
- MacroGenics, Inc. (United States)
- Ferring BV (Switzerland)
Recent Developments
- In March 2022, Nextera AS and Zelluna Immunotherapy AS entered a strategic collaboration to build optimal TCRs for cancer immunotherapy.
- In February 2022, Biomunex Pharmaceuticals partnered with Institut Curie to develop a therapeutic candidate to treat hematological malignancies using Biomunex Pharmaceuticals' BiXAR technology for immunotherapy.
- In January 2021, Boehringer Ingelheim International GmbH and Enara Bio entered into a licensing agreement that focuses on the application of the Enara Bio Dark Antigen discovery platform for developing novel cancer immunotherapies.
Immunotherapy Drugs Key Market Trends
- Personalized Immunotherapy: With recent advances in precision medicine, genomics, and genetic engineering, the market is witnessing a surge in demand for personalized immunotherapy. This practice mainly deals with drug design based on each genetic make-up, history of diseases, and specific characteristics of his immune system. Trials conducted with personalized immunotherapies have shown many promising results: enhanced efficacy, reduced side effects. Business is investing heavily in the development of personalized immunotherapies, and this trend is predicted to continue to drive market growth and change the paradigm for the treatment of many diseases, such as autoimmune diseases and cancers.
- Combination Therapies: Combination therapies represent one of the more emerging areas within the immunotherapy market as researchers and clinicians seek ways to enhance treatment effectiveness and circumvent resistance mechanisms. The strategy is a combination of various types of immunotherapies, such as checkpoint inhibitors and cancer vaccines, or immunotherapy with classic treatments such as radiation and chemotherapy. Companies are spending more to develop combination treatments due to better clinical trial results from the latter. This trend is anticipated to prevail, thus driving the growth in the market and offering new hope to patients who suffer from complicated and treatment-resistant diseases.
Immunotherapy Drugs Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest Analysis, the growth of the immunotherapy drugs market is the result of increasing incidence of chronic diseases, enhancements in R&D, and due to new developments, such as combination treatments and personalized immunotherapy. Despite the high development costs and regulatory uncertainties posing challenges, the business is expected to grow at a very rapid pace offering new therapeutic options for patients affected by cancer, autoimmune diseases, and infectious diseases. New products and methods for unmet medical needs are bound to change the face of the market as research in immunotherapy continues to open new paths. The future of the market of immunotherapy drugs is substantial, and it may ensure considerable improvement of human health.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 247.44 billion |
| Market size value in 2031 | USD 772.87 billion |
| Growth Rate | 15.3% |
| Base year | 2023 |
| Forecast period | 2024–2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Immunotherapy Drugs Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Immunotherapy Drugs Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Immunotherapy Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunotherapy Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunotherapy Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Immunotherapy Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
